Clinical Trial Update: Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial investigating pemetrexed disodium for recurrent malignant gliomas, primary CNS lymphoma, or brain metastases; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Brain and Central Nervous System Tumors
• Lymphoma

Drugs mentioned

• Pemetrexed disodium (Pemetrexed disodium)

Snippet

Sponsor: Northwestern University | Conditions: Brain and Central Nervous System Tumors, Lymphoma | Phase 2 | Status: UNKNOWN